2 Materials and methods The Combat-JUDO trial was a 6-month multi-center, randomized, double-blinded, parallel, placebo-controlled trial (clinicaltrials.gov: NCT02794402) comparing once weekly subcutaneous injections of 2 mg exenatide extended release (Bydureon, AstraZeneca, Cambridge, UK) to placebo for the treatment of pediatric obesity (13)
Continued analysis is underway in this regard [10, 11]
The platform claims providers review submissions and send a prescription within one to two business days if approved
Research suggests supplementation may improve insulin sensitivity
What This Means for Prescribers and Pharmacists Tirzepatide Prescribing: If you are a state-licensed pharmacy or physician compounding under 503A or an outsourcing facility under 503B, you can no longer compound tirzepatide as the enforcement discretion period has ended